共抑制分子在脓毒症免疫功能障碍中作用的研究进展
脓毒症定义为感染引起宿主反应失调导致危及生命的器官功能障碍,其病理生理核心是早期严重炎症反应后机体为平衡免疫状态而启动抗炎反应,最终诱导以免疫细胞耗竭为特征的免疫麻痹或免疫抑制状态。在固有免疫和获得性免疫中,免疫细胞表面的共抑制分子如PD-1、TIM-3、CTLA-4、2B4、BTLA和NKG2A等在免疫抑制中发挥重要作用。阻断这些共抑制分子与其配体的相互作用可在脓毒症动物模型或患者中显著逆转免疫抑制状态。本文主要总结近年来这些共抑制分子在脓毒症免疫功能障碍中作用的新发现,为脓毒症免疫功能障碍的监测和治疗提供参考。
要点
- 脓毒症免疫功能障碍的特征是以免疫细胞耗竭为表现的免疫麻痹或免疫抑制状态。
- PD-1、TIM-3、CTLA-4、2B4、BTLA和NKG2A等共抑制分子在固有免疫和获得性免疫中参与免疫抑制。
- 阻断共抑制分子与其配体的相互作用可在脓毒症动物模型或患者中显著逆转免疫抑制状态。
- 本文总结近年来共抑制分子在脓毒症免疫功能障碍中作用的新发现,为监测和治疗提供参考。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为阻断共抑制分子与其配体的相互作用可显著逆转脓毒症动物模型或患者的免疫抑制状态,为脓毒症免疫功能障碍的监测和治疗提供参考。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. The pathophysiology core issue is that the body initiates a severe inflammatory reaction in response to the invasion of pathogenic microorganisms at the initial stage of disease. Subsequently, the body begins to fight inflammation in order to balance immunity status and eventually induces the immune paralysis or immunosuppressive state characterized by exhaustion of immune cell. Both in innate immunity and in acquired immunity, some co-suppressor molecules on the surface of immune cells play important roles in immunosuppression, such as, programmed death receptor-1 (PD-1), T cell immunoglobulin and mucin-containing protein-3 (TIM-3), cytotoxic T lymphocyte associated antigen-4 (CTLA-4), natural killer cell receptor 2B4 (CD244), B and T lymphocyte attenuator (BTLA) and NKG2A (CD94), et al. Blocking the interaction between these co-suppressor molecules and their ligands can significantly reverse the immunosuppressive state in septic animal models or patients. In order to provide a reference for the monitoring and treatment of sepsis immune dysfunction, this article mainly summarizes the new findings on the role of those co-suppressor molecules in sepsis immune dysfunction in recent years.
参考来源
- Gao J, Liu Z, Liu Z, et al. [Study progress of role of co-suppressor molecules in sepsis immune dysfunction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32148245. doi:10.3760/cma.j.cn121430-20190916-00023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。